Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.

Between 1984 and 1990, 94 women presenting to the Edinburgh Breast Unit with operable breast cancer of 4 cm or greater in diameter (T2, T3, N0, N1, M0) were given preoperative systemic therapy. Initially, all women received hormone therapy, with CHOP (cyclophosphamide 1 g m(-2), doxorubicin 50 mg m(...

Descripción completa

Detalles Bibliográficos
Autores principales: Cameron, D. A., Anderson, E. D., Levack, P., Hawkins, R. A., Anderson, T. J., Leonard, R. C., Forrest, A. P., Chetty, U.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228097/
https://www.ncbi.nlm.nih.gov/pubmed/9376273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228097/
https://www.ncbi.nlm.nih.gov/pubmed/9376273

Ejemplares similares